Dispositions of di‐ and mono‐(2‐ethylhexyl) phthalate in newborn infants subjected to exchange transfusions

Abstract
The dispositions of the plasticizer di‐(2‐ethylhexyl) phthalate (DEHP) and its primary metabolite mono‐(2‐ethylhexyl) phthalate (MEHP) were studied in newborn infants subjected to exchange transfusions. During a single exchange transfusion the amounts of DEHP and MEHP infused ranged from 0±8‐3±3 and 0±05‐0±20 mg kg‐1 body weight, respectively. There were indications that about 30% of the infused DEHP originated from parts of the transfusion set other than the blood bag. Approximately 30% of the infused amount of DEHP was withdrawn during the course of each transfusion. Immediately after the transfusions the plasma levels of DEHP ranged between 5±8 and 19±6 μg ml‐1, and subsequently they declined rapidly. This decline, probably reflecting distribution of DEHP within the body, was followed by a slower elimination phase. The half‐life of this phase was approximately 10 h. The maximal plasma levels of MEHP were about 5 μg ml‐1. In one pre‐term infant the elimination of MEHP was slower than its formation, whereas in one full‐term newborn the formation appeared to be rate‐limiting for the elimination.